Houston Methodist researchers identify COVID-19 risk factors in young adults

Translate to Spanish or other 102 languages!

Khalil AbuSharekh, Houston Methodist Medical staff in Houston Methodist’s hospitals are kept very busy with COVID cases surging once again.

Mega Doctor News

- Advertisement -

By Houston Methodist 

Newswise – With the age of COVID-19 hospitalizations skewing younger in this fourth surge, a newly published Houston Methodist study looked at data from the first three surges within its hospitals that revealed clues about COVID’s risk factors among young adults.

Lead author Edward A. Graviss, Ph.D., M.P.H., F.I.D.S.A., an Associate Professor of Pathology and Genomic Medicine with the Houston Methodist Research Institute, and his team investigated demographic and clinical risk factors for severe disease in hospitalized young adult COVID-19 patients age 18-29 years across Houston Methodist’s system of seven hospitals. Their analysis took place from March 1 to December 7, during the first three COVID-19 surges in 2020. They also looked at readmission rates and accompanying severe disease diagnoses within 30 days after these patients were discharged from the hospital.

- Advertisement -

With patients well-distributed among Houston Methodist’s eight hospitals across the greater Houston area, the 1,853 young adult patients were 20% non-Hispanic white, 32% non-Hispanic Black and 43% Hispanic or Latino. Women made up 62% of patients, with 12% being pregnant. While these patients were relatively healthy, 68% were overweight or obese. The most common comorbidities among the patients were asthma, mental health disorders, hypertension and diabetes. While all patients had COVID-positive PCR tests and were potentially infectious at some point during their diagnostic encounter, only 43% reported COVID-19 symptoms at admission. 

Hispanic men were more likely to develop severe disease outcomes, and increasing age, asthma history, congestive heart failure, cerebrovascular disease and diabetes were predictive of severe disease diagnoses within 30 days of initial hospitalization. Hispanic ethnicity, non-Hispanic Black race, obesity, asthma and myocardial infarction history, and household exposure were predictive of hospital readmission after 30 days.

Relatively few young adult patients received respiratory interventions, such as ventilator support, during their initial diagnostic encounter, with 11% receiving supplemental oxygen and 3% requiring intensive care. While 96% of the patients were discharged home from their initial hospitalization, 15% of them returned to the hospital within 30 days. Of the inpatient admissions, four patients (1%) died during their initial hospitalization and four more died after being discharged to another institution.

Overall, within 30 days of their first encounter, 17% of patients were diagnosed with pneumonia and 8% were diagnosed with at least one additional critical diagnosis, such as sepsis, myocardial infarction, cerebrovascular event, cardiac arrest, pulmonary embolism, thrombosis, acute respiratory distress syndrome (ARDS) and the like, to be classified as having severe COVID-19 disease. 

- Advertisement -

The authors say the study demonstrates a significant risk of severe disease and readmission among young adults, especially those in marginalized communities and in individuals with comorbidities. They emphasize a need for more COVID-19 awareness and prevention among young adults and continued investigation of risk factors for severe disease, readmission, and long-term consequences of COVID-19. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Breast Cancer Treatments Offer More Personalized Options for Patients in 2026

Advances in genetic testing and clinical research are giving physicians new ways to select breast cancer treatments based on individual patients' needs, according to Dr. Joseph Murray, senior medical director at Caris Life Sciences

Dr. Alvaro Restrepo Urges Breast Cancer Survivors to Focus on Health Beyond Treatment

Breast cancer survivorship involves more than completing treatment, according to Dr. Alvaro Restrepo, a medical oncologist and hematologist at Texas Oncology McAllen, who urged patients to focus on physical health, emotional well-being, and long-term medical care.

Texas Oncology Experts Discuss Advances in Breast Cancer Detection, Treatment and Survivorship

Dr. Guillermo Lazo, Dr. Jasmine Gowarty, Dr. Joseph Murray, PhD, Dr. Nurul Wahid, MD, FACP, and Dr. Alvaro Restrepo gather during the October 16, 2026, breast cancer symposium in McAllen, Texas, focused on early detection, advances in treatment, and survivorship. Photo by Mega Doctor News.

STHS Children’s and Spirit Halloween Partner to Support Pediatric Patients

Spirit Halloween stores have partnered with the Auxiliary to South Texas Health System to benefit the Child Life Program at South Texas Health System Children’s. Through the collaboration, shoppers can use a 10% discount coupon at any participating Spirit Halloween store in the Rio Grande Valley, and a portion of the proceeds will support pediatric patients receiving care at the hospital.
- Advertisement -